GlassScriptPhysician profile
Susan Janet Lessing
NPI 1295054963
$462.37
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $13.71 · 2021: $16.99 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $134.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $101.80 | 2024 | Saphnelo |
| Novo Nordisk INC | $29.21 | 2019 | |
| Astellas Pharma US INC | $27.07 | 2019 | |
| Abbvie INC. | $26.69 | 2019 | |
| Abbott Laboratories | $24.67 | 2024 | Freestyle Libre 3 |
| Kci USA, INC. | $23.60 | 2019 | |
| Medtronic USA, INC. | $21.15 | 2019 | |
| Lilly USA, LLC | $16.99 | 2021 | |
| Amgen INC. | $16.67 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.47 | 2019 | |
| Smith+Nephew, INC. | $13.71 | 2020 | |
| Shire North American Group INC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Lessing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.